Oncotype DX testing and differences in use of chemotherapy by age in an integrated system

被引：0
|
作者：
Aller, Ashley
Lyon, Liisa
Habel, Laurel
Shirazi, Aida
Liu, Raymond
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-3822
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3822
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The impact of Oncotype DX testing on adjuvant chemotherapy decision making in 1-3 node positive breast cancer
    Malam, Yogeshkumar
    Rabie, Mohamed
    Geropantas, Konstantinos
    Alexander, Susanna
    Pain, Simon
    Youssef, Mina
    CANCER REPORTS, 2022, 5 (08)
  • [42] Current controversies in the use of Oncotype DX in early breast cancer
    Giachetti, Pier Paolo M. Berton
    Schianca, Ambra Carnevale
    Trapani, Dario
    Marra, Antonio
    Toss, Angela
    Marchio, Caterina
    Dieci, Maria Vittoria
    Gentilini, Oreste Davide
    Criscitiello, Carmen
    Kalinsky, Kevin
    Sparano, Joseph A.
    Curigliano, Giuseppe
    CANCER TREATMENT REVIEWS, 2025, 135
  • [43] Oncotype Dx Testing of Multiple Synchronous Tumors of the Breast--Is it necessary?
    Jin, Cao
    Jaffer, Shabnam
    Zeng, Jennifer
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 135 - 135
  • [44] Selecting Patients for Oncotype DX Testing Using Standard Clinicopathologic Information
    Robertson, Susan J.
    Pond, Greg R.
    Hilton, John
    Petkiewicz, Stephanie L.
    Ayroud, Yasmin
    Kos, Zuzana
    Gravel, Denis H.
    Stober, Carol
    Vandermeer, Lisa
    Arnaout, Angel
    Clemons, Mark
    CLINICAL BREAST CANCER, 2020, 20 (01) : 61 - 67
  • [45] Oncotype Dx Testing of Multiple Synchronous Tumors of the Breast-Is it necessary?
    Jin, Cao
    Jaffer, Shabnam
    Zeng, Jennifer
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 135 - 135
  • [46] ONCOLOGISTS' BARRIERS AND FACILITATORS FOR ONCOTYPE DX USE: QUALITATIVE STUDY
    Roberts, Megan C.
    Bryson, Amy
    Weinberger, Morris
    Dusetzina, Stacie B.
    Dinan, Michaela A.
    Reeder-Hayes, Katherine
    Wheeler, Stephanie B.
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2016, 32 (05) : 355 - 361
  • [47] The effect of Oncotype DX® on adjuvant chemotherapy treatment decisions in early breast cancer
    Rabie, M. A.
    Rankin, A.
    Burger, A.
    Youssef, M. M. G.
    ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2019, 101 (08) : 596 - 601
  • [48] Oncotype Dx assay and breast cancer in the United States: usage and concordance with chemotherapy
    Enewold, Lindsey
    Geiger, Ann M.
    Zujewski, JoAnne
    Harlan, Linda C.
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 151 (01) : 149 - 156
  • [49] Will oncotype DX DCIS testing guide therapy? A single-institution correlation of oncotype DX DCIS results with histopathologic findings and clinical management decisions
    Lin, Chieh-Yu
    Mooney, Kelly
    Choy, Winward
    Yang, Soo-Ryum
    Barry-Holson, Keegan
    Horst, Kathleen
    Wapnir, Irene
    Allison, Kimberly
    MODERN PATHOLOGY, 2018, 31 (04) : 562 - 568
  • [50] Oncotype Dx assay and breast cancer in the United States: usage and concordance with chemotherapy
    Lindsey Enewold
    Ann M. Geiger
    JoAnne Zujewski
    Linda C. Harlan
    Breast Cancer Research and Treatment, 2015, 151 : 149 - 156
12345